Clinical Microbiology Newsletter
Volume 32, Issue 12 , Pages 89-96, 15 June 2010

Streptococcus suis Infections in Humans: What is the prognosis for Western countries? (Part I)

  • Marcelo Gottschalk, D.V.M., Ph.D.

      Affiliations

    • Groupe de Recherche sur les Maladies Infectieuses du Porc (GREMIP) and Centre de Recherche en Infectiologie Porcine (CRIP); Faculté de Médecine Vétérinaire, Université de Montréal, Québec, Canada
    • Corresponding Author InformationMailing address: M. Gottschalk, GREMIP, Faculté de médecine vétérinaire, Université de Montréal, 3200 rue Sicotte, St-Hyacinthe, Québec, J2S 2M2, Canada. Tel.: 450-773-8521, ext. 8374. Fax: 450-778-8108
  • ,
  • Jiangu Xu, M.D.

      Affiliations

    • State Key Laboratory for Infectious Disease Prevention and Control and National Institute for Communicable Disease Control and Prevention (China CDC, Beijing, China)
  • ,
  • Marie-Pier Lecours, M.Sc.

      Affiliations

    • Groupe de Recherche sur les Maladies Infectieuses du Porc (GREMIP) and Centre de Recherche en Infectiologie Porcine (CRIP); Faculté de Médecine Vétérinaire, Université de Montréal, Québec, Canada
  • ,
  • Daniel Grenier, Ph.D.

      Affiliations

    • Groupe de Recherche en Écologie Buccale, Faculté de Médecine Dentaire, Université Laval, Québec City, Québec, Canada
  • ,
  • Nahuel Fittipaldi, Ph.D.

      Affiliations

    • Groupe de Recherche sur les Maladies Infectieuses du Porc (GREMIP) and Centre de Recherche en Infectiologie Porcine (CRIP); Faculté de Médecine Vétérinaire, Université de Montréal, Québec, Canada
    • Present address: Center for Molecular and Translational Human Infectious Diseases Research, The Methodist Hospital Research Institute, Houston, Texas

Abstract 

Infections caused by Streptococcus suis are an important economic problem in the swine industry. Moreover, S. suis (especially serotype 2) is an agent of zoonosis that has the potential to afflict those who are in close contact with infected pigs or pork-derived products. Although sporadic cases of S. suis infections in humans have been reported during the last 40 years, a large outbreak in China emerged in 2005. The severity of the infection in humans during the outbreak, such as clinical signs of streptococcal toxic shock syndrome, attracted much attention from the scientific community and the public press. This two-part review will focus on this organism and the infections it causes, highlighting the differences between Asian and Western countries, particularly with respect to its epidemiology. In part I, the general characteristics of the organism are reviewed, as well as the clinical characteristics associated with S. suis infection in humans, the pathogenesis of infection and associated virulence factors, and, finally, the interactions between S. suis and the host's immune system.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Part II of this article will appear in the July 1, 2010 issue of CMN (Vol. 32. No. 13).

PII: S0196-4399(10)00027-9

doi:10.1016/j.clinmicnews.2010.05.005

Clinical Microbiology Newsletter
Volume 32, Issue 12 , Pages 89-96, 15 June 2010